UK markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.4950+0.1350 (+5.72%)
As of 12:57PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7774
Avg. Estimate-0.18-0.09-0.17-0.02
Low estimate-0.25-0.2-0.95-0.32
High estimate-0.1-0.030.170.51
Year ago EPS-0.46-0.37-2.03-0.17
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7775
Avg. Estimate47.04M66.17M324.39M417.43M
Low estimate37.8M49M292.8M294.66M
High estimate60M83.4M384.5M664.8M
Year ago sales25.79MN/A116.33M324.39M
Sales growth (year/est)82.40%N/A178.80%28.70%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.61-0.43-0.480.05
Actual EPS-0.46-0.37-0.50.34
Difference0.150.06-0.020.29
Surprise %24.60%14.00%-4.20%580.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.18-0.09-0.17-0.02
7 days ago-0.18-0.09-0.170
30 days ago-0.21-0.1-0.40.05
60 days ago-0.21-0.11-0.440.2
90 days ago0.1-0.19-0.280.51
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days222N/A
Up last 30 days4353
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesESPRIndustrySector(s)S&P 500
Current qtr.60.90%N/AN/AN/A
Next qtr.75.70%N/AN/AN/A
Current year91.60%N/AN/AN/A
Next year88.20%N/AN/AN/A
Next 5 years (per annum)16.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A